MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2019 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBALSPB |
Anteile |
60.5 M |
Marktkapitalisierung |
$ 76.9 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Eiger BioPharmaceuticals
EIGR
|
- | -9.21 % | $ 2.55 M | Nasdaq Global Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
BELLUS Health
BLU
|
- | - | $ 2.47 B | Nasdaq Global Select Market |  Canada |
 |
bluebird bio
BLUE
|
- | - | $ 546 M | Nasdaq Global Select Market,SPB | USA |
 |
Intra-Cellular Therapies
ITCI
|
- | - | $ 13.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Marinus Pharmaceuticals
MRNS
|
- | - | $ 29.6 M | Nasdaq Global Select Market | USA |
 |
Merrimack Pharmaceuticals
MACK
|
- | - | $ 216 M | Nasdaq Global Market | USA |
 |
CASI Pharmaceuticals
CASI
|
- | - | $ 35.4 M | Nasdaq Capital Market | USA |
 |
ContraFect Corporation
CFRX
|
- | -5.16 % | $ 5.39 M | Nasdaq Capital Market | USA |
 |
Sigilon Therapeutics
SGTX
|
- | - | $ 728 M | Nasdaq Global Select Market | USA |
 |
Rubius Therapeutics
RUBY
|
- | -33.55 % | $ 7.81 M | Nasdaq Global Select Market | USA |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
TRACON Pharmaceuticals
TCON
|
- | -1.38 % | $ 46.8 M | Nasdaq Capital Market | USA |
 |
Mirati Therapeutics
MRTX
|
- | - | $ 3.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Revance Therapeutics
RVNC
|
- | - | $ 309 M | Nasdaq Global Select Market | USA |
 |
Allogene Therapeutics
ALLO
|
$ 1.19 | 5.8 % | $ 263 M | Nasdaq Global Select Market,SPB | USA |
 |
InVivo Therapeutics Holdings Corp.
NVIV
|
- | -37.48 % | $ 476 K | Nasdaq Capital Market | USA |
 |
Epizyme
EPZM
|
- | - | $ 249 M | Nasdaq Global Select Market | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
- | -9.72 % | $ 5.89 M | Nasdaq Capital Market | USA |
 |
Processa Pharmaceuticals
PCSA
|
$ 1.93 | -0.77 % | $ 2.53 M | Nasdaq Global Select Market | USA |
 |
Forward Pharma A/S
FWP
|
- | -0.75 % | $ 18.7 M | Nasdaq Capital Market |  Danmark |
 |
Orchard Therapeutics plc
ORTX
|
- | 1.02 % | $ 90.8 M | Nasdaq Global Select Market |  Britain |
 |
La Jolla Pharmaceutical Company
LJPC
|
- | - | $ 154 M | Nasdaq Capital Market | USA |
 |
Oyster Point Pharma
OYST
|
- | - | $ 300 M | Nasdaq Global Select Market | USA |
 |
Nabriva Therapeutics plc
NBRV
|
- | - | $ 4.55 M | Nasdaq Global Select Market |  Irlanda |
 |
Intercept Pharmaceuticals
ICPT
|
- | - | $ 643 M | Nasdaq Global Select Market,SPB | USA |
 |
NGM Biopharmaceuticals
NGM
|
- | - | $ 127 M | Nasdaq Global Select Market,SPB | USA |
 |
Regulus Therapeutics
RGLS
|
- | - | $ 155 M | Nasdaq Global Select Market | USA |
 |
9 Meters Biopharma
NMTR
|
- | -42.97 % | $ 1.05 M | Nasdaq Global Select Market | USA |
 |
Chinook Therapeutics
KDNY
|
- | - | $ 2.6 B | Nasdaq Global Select Market | USA |
 |
Lumos Pharma
LUMO
|
- | - | $ 35.3 M | Nasdaq Global Select Market | USA |
 |
Syros Pharmaceuticals
SYRS
|
- | -8.44 % | $ 3.4 M | Nasdaq Global Select Market | USA |
 |
Gamida Cell Ltd.
GMDA
|
- | -18.25 % | $ 5.04 M | Nasdaq Global Market |  Israel |
 |
GT Biopharma
GTBP
|
$ 4.89 | -7.12 % | $ 27 M | Nasdaq Capital Market | USA |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
Bellerophon Therapeutics
BLPH
|
- | -74.18 % | $ 955 K | Nasdaq Capital Market | USA |
 |
MannKind Corporation
MNKD
|
$ 3.94 | 5.63 % | $ 1.2 B | Nasdaq Global Market | USA |
 |
MediWound Ltd.
MDWD
|
$ 14.17 | 5.83 % | $ 386 M | Nasdaq Global Select Market | Israel |
 |
Intellia Therapeutics
NTLA
|
$ 12.3 | 3.67 % | $ 1.33 B | Nasdaq Global Market,SPB | USA |
 |
Oramed Pharmaceuticals
ORMP
|
$ 4.12 | 3.0 % | $ 171 M | Nasdaq Global Select Market | Israel |
 |
Pharming Group N.V.
PHAR
|
$ 12.46 | -3.63 % | $ 8.58 B | Nasdaq Global Select Market |  Niderland |
 |
NanoViricides
NNVC
|
$ 1.41 | -1.4 % | $ 28.5 M | NYSE American | USA |
 |
Omeros Corporation
OMER
|
$ 18.17 | -0.55 % | $ 1.15 B | Nasdaq Global Select Market | USA |
 |
PMV Pharmaceuticals
PMVP
|
$ 1.33 | -3.62 % | $ 69.9 M | Nasdaq Global Select Market | USA |
 |
PTC Therapeutics
PTCT
|
$ 68.96 | 1.23 % | $ 5.48 B | Nasdaq Global Select Market,SPB | USA |
 |
Puma Biotechnology
PBYI
|
$ 10.7 | 4.7 % | $ 535 M | Nasdaq Global Select Market | USA |
 |
PDS Biotechnology Corporation
PDSB
|
$ 1.29 | -8.87 % | $ 59.8 M | Nasdaq Capital Market | USA |
 |
Protalix BioTherapeutics
PLX
|
$ 2.69 | 2.87 % | $ 211 M | NYSE American | Israel |
 |
PainReform Ltd.
PRFX
|
$ 0.77 | 7.75 % | $ 499 K | Nasdaq Capital Market | Israel |